FDA Inspection 875112 — SHANGHAI APOLO MEDICAL TECHNOLOGY CO., LTD.

SHANGHAI APOLO MEDICAL TECHNOLOGY CO., LTD. — FEI 3007120647

The FDA completed an inspection of SHANGHAI APOLO MEDICAL TECHNOLOGY CO., LTD. on March 27, 2014 in Shanghai. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 6 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 27, 2014
Fiscal Year
2014
Product Type
Devices
Project Area
Compliance: Devices
Location
Shanghai (China)

Citations

IDCFRDescription
1471421 CFR 820.30(c)Design input - Lack of or inadequate procedures
1471621 CFR 820.30(f)Design verification - output does not meet input requirement
1472221 CFR 820.40Procedures not adequately established or maintained
232821 CFR 820.22Quality audits - auditor independence
313021 CFR 820.100(a)Lack of or inadequate procedures
367821 CFR 820.30(g)Design Validation - Risk analysis not performed/inadequate